{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:34:24Z","timestamp":1791279264492,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1054\/blre.2001.0149","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T14:55:24Z","timestamp":1032447324000},"page":"61-67","source":"Crossref","is-referenced-by-count":35,"title":["Cancer and thrombosis revisited"],"prefix":"10.1054","volume":"15","author":[{"given":"R.","family":"Hoffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Haim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1054\/blre.2001.0149_RF1","series-title":"Phlegmasia alba doleus. Lectures on clinical medicine, delivered at the hotel Diew Paris","author":"Trousseau","year":"1872"},{"key":"10.1054\/blre.2001.0149_RF2","article-title":"Venous thromboembolism in malignancy","volume":"28","author":"Rickles","year":"1998","journal-title":"Haemostasis"},{"key":"10.1054\/blre.2001.0149_RF3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.160.6.769","article-title":"Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors","volume":"160","author":"Hansson","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1054\/blre.2001.0149_RF4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-2007-994919","article-title":"Pathophysiology of the thrombophilic state in the cancer patient","volume":"25","author":"Falanga","year":"1999","journal-title":"Semin Thromb Haemost"},{"key":"10.1054\/blre.2001.0149_RF5","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1759::AID-CNCR1>3.0.CO;2-7","article-title":"Diagnosis of cancer associated vascular disorders","volume":"77","author":"Naschitz","year":"1996","journal-title":"Cancer"},{"key":"10.1054\/blre.2001.0149_RF6","first-page":"57","article-title":"Essential thrombocythemia \u2013 update on pathogenesis and therapy","volume":"11","author":"Lugassy","year":"1998","journal-title":"Cancer J"},{"key":"10.1054\/blre.2001.0149_RF7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0002-9343(96)00457-3","article-title":"Cardiac vascular vegetations in cancer patients: a prospective echocardiographic study of 200 patients","volume":"102","author":"Edoute","year":"1997","journal-title":"Am J Med"},{"key":"10.1054\/blre.2001.0149_RF8","first-page":"262","article-title":"Thrombosis and cancer","volume":"27","author":"Arkel","year":"2000","journal-title":"Seminars in Oncology"},{"key":"10.1054\/blre.2001.0149_RF9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/00325481.1993.11701721","article-title":"Thrombosis in patients with cancer","volume":"93","author":"Bona","year":"1993","journal-title":"Postgrad Med"},{"key":"10.1054\/blre.2001.0149_RF10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF01307180","article-title":"Hemostatic alterations in cancer patients","volume":"11","author":"Rickles","year":"1992","journal-title":"Cancer Met Rev"},{"key":"10.1054\/blre.2001.0149_RF11","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/ajcp\/88.5.596","article-title":"Abnormalities of blood coagulation in patients with cancer","volume":"88","author":"Edwards","year":"1987","journal-title":"Am J Clin Patho"},{"key":"10.1054\/blre.2001.0149_RF12","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood.V91.9.3093","article-title":"The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia","volume":"91","author":"Barbui","year":"1998","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0149_RF13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0889-8588(05)70347-6","article-title":"Coagulation disorders in cancer","volume":"10","author":"Goad","year":"1996","journal-title":"Hematol\/Oncol Clin North Am"},{"key":"10.1054\/blre.2001.0149_RF14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-2007-1002674","article-title":"Fibrinolysis and cancer","volume":"16","author":"Kwaan","year":"1990","journal-title":"Semin Thromb Hemost"},{"key":"10.1054\/blre.2001.0149_RF15","first-page":"2244","article-title":"Deficient activity of von Willebrand\u2019s factor-cleaving protease in patients with disseminated malignancies","volume":"59","author":"Oleksowicz","year":"1999","journal-title":"Cancer Res"},{"key":"10.1054\/blre.2001.0149_RF16","first-page":"748","article-title":"Tissue factor activity in leukemic cells","volume":"59","author":"Andoh","year":"1987","journal-title":"Special reference to disseminated intravascular coagulation. Cancer"},{"key":"10.1054\/blre.2001.0149_RF17","first-page":"170","article-title":"The tissue factor pathway of blood coagulation","volume":"29","author":"Nemerson","year":"1992","journal-title":"Semin Hematol"},{"key":"10.1054\/blre.2001.0149_RF18","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(95)91690-3","article-title":"Extrinsic-pathway activation in cancer with high factor VII and tissue factor","volume":"346","author":"Kakkar","year":"1995","journal-title":"Lancet"},{"key":"10.1054\/blre.2001.0149_RF19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0145-2126(95)00107-7","article-title":"Tissue factor expression in human leukemic cells","volume":"20","author":"Hair","year":"1996","journal-title":"Leuk Res"},{"key":"10.1054\/blre.2001.0149_RF20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/107602960000600102","article-title":"Elevated tissue factor levels in leukemic cell homogenate","volume":"6","author":"Nakasaki","year":"2000","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1054\/blre.2001.0149_RF21","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1046\/j.1365-2168.1999.01153.x","article-title":"Role of tissue factor expression on tumour cell invasion and growth of experimental pancreatic adeno-carcinoma","volume":"86","author":"Kakkar","year":"1999","journal-title":"Br J Surg"},{"key":"10.1054\/blre.2001.0149_RF22","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/sj.leu.2401448","article-title":"Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents","volume":"13","author":"Zhu","year":"1999","journal-title":"Leukemia"},{"key":"10.1054\/blre.2001.0149_RF23","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/sj.bjc.6690073","article-title":"Expression of tissue factor in non small cell lung cancers and its relationship to metastasis","volume":"79","author":"Sawada","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1054\/blre.2001.0149_RF24","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1055\/s-0037-1615384","article-title":"Tissue factor expression and metastatic potential of colorectal cancer","volume":"80","author":"Shigemori","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.2001.0149_RF25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/hp.2000.6547","article-title":"Tissue factor expression and angiogenesis in human prostate carcinoma","volume":"31","author":"Abdulkadir","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1054\/blre.2001.0149_RF26","first-page":"164","article-title":"Tissue factor expression in breast cancer tissues","volume":"83","author":"Ueno","year":"2000","journal-title":"Its correlation with prognosis and plasma concentration. Br J Cancer"},{"key":"10.1054\/blre.2001.0149_RF27","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1021\/bi00341a041","article-title":"Isolation and characterization of cancer procoagulant: a cysteine protease from malignant tissue","volume":"24","author":"Falanga","year":"1985","journal-title":"Biochemistry"},{"key":"10.1054\/blre.2001.0149_RF28","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V66.6.1261.1261","article-title":"Cysteine proteinase procoaulant from amnion-chorion","volume":"66","author":"Gordon","year":"1985","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0149_RF29","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1182\/blood.V86.9.3535.bloodjournal8693535","article-title":"Effect of all trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia","volume":"86","author":"De Stefano","year":"1995","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0149_RF30","first-page":"11","article-title":"Cancer procoagulant in acute non-lymphoid leukemia","volume":"64","author":"Donati","year":"1990","journal-title":"Relationship of enzyme detection to disease activity. Thromb Haemost"},{"key":"10.1054\/blre.2001.0149_RF31","first-page":"156","article-title":"Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by retinoic acid","volume":"8","author":"Falanga","year":"1994","journal-title":"Leukemia"},{"key":"10.1054\/blre.2001.0149_RF32","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood.V86.3.1072.1072","article-title":"Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia given all trans retinoic acid","volume":"86","author":"Falanga","year":"1995","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0149_RF33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3835(99)00230-X","article-title":"Activation of blood coagulation and the activity of cancer procoagulant (EL 3, 4, 22, 26) in breast cancer","volume":"146","author":"Mielicki","year":"1999","journal-title":"Cancer Lett"},{"key":"10.1054\/blre.2001.0149_RF34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid","volume":"21","author":"Senger","year":"1983","journal-title":"Science"},{"key":"10.1054\/blre.2001.0149_RF35","series-title":"Regulation of angiogenesis","article-title":"Vascular permeability factor\/vascular endothelial growth factor: A multi funcional aniogenesis factor","author":"Brown","year":"1998"},{"key":"10.1054\/blre.2001.0149_RF36","first-page":"157","article-title":"The effect of dexamethasone on pro-inflammatory cytokine expression, cell growth and maturation during granulocytic differentiation of acute promyelocytic leukemia cells","volume":"6","author":"Gianni","year":"1995","journal-title":"Eur Cytokine Network"},{"key":"10.1054\/blre.2001.0149_RF37","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1172\/JCI116928","article-title":"Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions","volume":"92","author":"Giavazzi","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1054\/blre.2001.0149_RF38","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1054\/bjoc.2000.1439","article-title":"Inhibition of angiogenesis and tumor growth by VEGF 121-toxin conjugate: differential effect on proliferating endothelial cells","volume":"83","author":"Wild","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1054\/blre.2001.0149_RF39","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1067\/msy.2000.107265","article-title":"Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma","volume":"128","author":"Maehara","year":"2000","journal-title":"Surg"},{"key":"10.1054\/blre.2001.0149_RF40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0945-053X(00)00079-2","article-title":"Effects of thrombin \/ thrombosis in angiogenesis and tumour progression","volume":"19","author":"Maragoudakis","year":"2000","journal-title":"Matrix Biol"},{"key":"10.1054\/blre.2001.0149_RF41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s000180050495","article-title":"Matrix metalloproteinases in tumor invasion","volume":"57","author":"Johansson","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1054\/blre.2001.0149_RF42","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0959-8049(00)00157-X","article-title":"No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer","volume":"36","author":"Reijerkerk","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1054\/blre.2001.0149_RF43","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/10525","article-title":"Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis","volume":"5","author":"Hulett","year":"1999","journal-title":"Nat Med"},{"key":"10.1054\/blre.2001.0149_RF44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/1097-0215(20000920)89:5<431::AID-IJC6>3.0.CO;2-V","article-title":"Urokinase type plasminogen activator and its receptor in colorectal cancer: Independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets","volume":"89","author":"Yang","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1054\/blre.2001.0149_RF45","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-0038-1642691","article-title":"Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von-Willebrand factor on tumor adhesion in-vitro and metastasis in-vivo","volume":"74","author":"Nierodzik","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.2001.0149_RF46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ajh.2830160213","article-title":"Tumor interaction with hemostasis: The rationale for use of platelet inhibitors and anticoagulants in treatment of cancer","volume":"16","author":"AL-Mondhiry","year":"1984","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0149_RF47","first-page":"105","article-title":"Beta thromboglobulin and platelet factor 4 in patients with cancer","volume":"14","author":"AL-Mandhiry","year":"1983","journal-title":"Correlation with the stage of disease and the effect of chemotherapy. Am J Hematol"},{"key":"10.1054\/blre.2001.0149_RF48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0049-3848(91)90103-4","article-title":"Circulating activated platelets in myeloproliferative disorders","volume":"61","author":"Wehmeier","year":"1991","journal-title":"Thromb Res"},{"key":"10.1054\/blre.2001.0149_RF49","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1182\/blood.V71.4.844.844","article-title":"Platelets in tumor metastasis: generation of ADP by tumor cells is specific but unrelated to metastatic potential","volume":"71","author":"Grignani","year":"1988","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0149_RF50","first-page":"1998","article-title":"Hemostatic abnormalities in untreated cancer","volume":"5","author":"Nand","year":"1987","journal-title":"Incidence and correlation with thrombotic and hemorrhagic complications. J Clin Oncol"},{"key":"10.1054\/blre.2001.0149_RF51","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1365-2141.1999.01223.x","article-title":"Hemostatic and fibrinolytic responses to bone marrow transplantation","volume":"104","author":"Brown","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0149_RF52","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/1097-0142(19840615)53:12<2607::AID-CNCR2820531206>3.0.CO;2-T","article-title":"Tamoxifen treatment of metastatic breast cancer and AT III levels","volume":"53","author":"Enck","year":"1984","journal-title":"Cancer"},{"key":"10.1054\/blre.2001.0149_RF53","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJM199210153271604","article-title":"Deep vein thrombosis and the incidence of subsequent symptomatic cancer","volume":"327","author":"Prandoni","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2001.0149_RF54","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199804233381701","article-title":"The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism","volume":"338","author":"Sorensen","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2001.0149_RF55","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-125-10-199611150-00001","article-title":"Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis","volume":"125","author":"Cornuz","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1054\/blre.2001.0149_RF56","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"Sorensen","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2001.0149_RF57","first-page":"527","article-title":"Deep vein thrombosis of the leg","volume":"129","author":"Kakkar","year":"1970","journal-title":"Is there a \u2018high risk\u2019 group? Am J Surg"},{"key":"10.1054\/blre.2001.0149_RF58","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(86)91158-X","article-title":"Pre-operative identification of patients at high risk of deep vein thrombosis after elective major abdominal surgery","volume":"1","author":"Sue-Ling","year":"1986","journal-title":"Lancet"},{"key":"10.1054\/blre.2001.0149_RF59","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-0038-1657514","article-title":"Prevention of post operative deep leg vein thrombosis in patients with cancer","volume":"78","author":"Gallus","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.2001.0149_RF60","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-2007-994925","article-title":"Prevention of venous thromboembolism in cancer patients","volume":"25","author":"Kakkar","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1054\/blre.2001.0149_RF61","article-title":"Thrombophylaxis in the cancer patient","volume":"28","author":"Kakkar","year":"1998","journal-title":"Haemostasis"},{"key":"10.1054\/blre.2001.0149_RF62","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-0038-1657514","article-title":"Prevention of post-operative deep leg vein thrombosis in patients with cancer","volume":"78","author":"Gallus","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.2001.0149_RF63","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/bjs.1800750213","article-title":"Low molecular weight heparin compared to UFH in prevention of postoperative thrombosis","volume":"75","author":"Samama","year":"1988","journal-title":"Br J Surg"},{"key":"10.1054\/blre.2001.0149_RF64","article-title":"Use of LMWH in malignancy","volume":"2","author":"Godwin","year":"1996","journal-title":"Clin Appl Thromb Haemost"},{"key":"10.1054\/blre.2001.0149_RF65","doi-asserted-by":"crossref","unstructured":"Durica, S. S. Venous thromboembolism in the cancer patient, Curr Opin Hematol 1997; 4: 306\u2013311.","DOI":"10.1097\/00062752-199704050-00002"},{"key":"10.1054\/blre.2001.0149_RF66","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/bjs.1800840605","article-title":"Low molecular weight heparin and uinfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta analysis","volume":"84","author":"Koch","year":"1997","journal-title":"Br J Surg"},{"key":"10.1054\/blre.2001.0149_RF67","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/bjs.1800820421","article-title":"Low molecular weight heparin started before surgery as prophylaxis against DVT: 2500 vs 5000 Xa I units in 2070 patients","volume":"82","author":"Bergquist","year":"1995","journal-title":"Br J Surg"},{"key":"10.1054\/blre.2001.0149_RF68","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199807093390204","article-title":"Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery","volume":"339","author":"Agnelli","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2001.0149_RF69","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00006123-199811000-00039","article-title":"Enoxaparin increases the incidence of post-operative intracranial hemorrhage when inherited preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors","volume":"43","author":"Dickinson","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1054\/blre.2001.0149_RF70","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(94)90008-6","article-title":"Double-blind randomized trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer","volume":"343","author":"Levine","year":"1994","journal-title":"Lancet"},{"key":"10.1054\/blre.2001.0149_RF71","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-76-3-112-6-423","article-title":"Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomzed prospective trial","volume":"112","author":"Bern","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1054\/blre.2001.0149_RF72","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0038-1650254","article-title":"Upper extremity deep venous thrombosis in cancer patients with venous access devices-Prophylaxis with a low molecular weight heparin (Fragmin)","volume":"75","author":"Monreal","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.2001.0149_RF73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","article-title":"The long-term clinical course of acute deep venous thrombosis","volume":"125","author":"Prandoni","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1054\/blre.2001.0149_RF74","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-130-10-199905180-00003","article-title":"Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis","volume":"130","author":"Gould","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1054\/blre.2001.0149_RF75","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1055\/s-0037-1615937","article-title":"Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread","volume":"82","author":"Hettiarachchi","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.2001.0149_RF76","first-page":"66","article-title":"The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolism","volume":"149","author":"Schulman","year":"1999","journal-title":"Duration of Anticoagulation Study Group. Vienna Med Wochenschr"},{"key":"10.1054\/blre.2001.0149_RF77","first-page":"409","article-title":"A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis","volume":"338","author":"Decousus","year":"1998","journal-title":"Preventi Risque d\u2019Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med"},{"key":"10.1054\/blre.2001.0149_RF78","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00000421-200002000-00020","article-title":"Warfarin is safe as secondary prophylaxis in patients with cancer and a previous episode of venous thrombosis","volume":"23","author":"Bona","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"10.1054\/blre.2001.0149_RF79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jnci\/91.1.22","article-title":"Inhibition of metastases by anticoagulants","volume":"91","author":"Hejna","year":"1999","journal-title":"Natl Cancer Inst"},{"key":"10.1054\/blre.2001.0149_RF80","first-page":"48","article-title":"The use of heparin for treating human malignancies","volume":"29 suppl S1","author":"Ornstein","year":"1999","journal-title":"Haemostasis"},{"key":"10.1054\/blre.2001.0149_RF81","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00063198-200007000-00009","article-title":"Cancer thrombosis and anticoagulants","volume":"6","author":"Ornstein","year":"2000","journal-title":"Curr Opin Pulm Med"},{"key":"10.1054\/blre.2001.0149_RF82","first-page":"369","article-title":"The influence of anticlotting agents on transplantation and growth of tumor tissue","volume":"16","author":"Goerner","year":"1930","journal-title":"J Lab Clin Med"},{"key":"10.1054\/blre.2001.0149_RF83","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archinte.1995.00430060059007","article-title":"Treatment of deep venous thrombosis with low molecular weight heparins: a meta-analysis","volume":"155","author":"Lensing","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1054\/blre.2001.0149_RF84","first-page":"269","article-title":"Low molecular weight heparins and unfractionated heparin in the treatment of patients with acute venous thrombosis","volume":"100","author":"Siragusa","year":"1996","journal-title":"Results of a meta-analysis. Am J Med"},{"key":"10.1054\/blre.2001.0149_RF85","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-0037-1615131","article-title":"Heparin and cancer","volume":"80","author":"Zacharski","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.2001.0149_RF86","first-page":"815","article-title":"Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvis cancer surgery: a prospective randomized double-blind trial","volume":"16","author":"von Tempelhoff","year":"2000","journal-title":"Int J Oncol"},{"key":"10.1054\/blre.2001.0149_RF87","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00000421-199502000-00003","article-title":"Cancer incidence and mortality in patients with heart disease: Effect of oral anticoagulant therapy","volume":"18","author":"Carpi","year":"1995","journal-title":"Am J Clin Oncol"},{"key":"10.1054\/blre.2001.0149_RF88","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJM200006293422604","article-title":"Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism","volume":"342","author":"Schulman","year":"2000","journal-title":"Duration of Anticoagulation Trial. N Engl J Med"},{"key":"10.1054\/blre.2001.0149_RF89","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7326\/0003-4819-130-8-199904200-00004","article-title":"Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism","volume":"130","author":"Rodeghiero","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1054\/blre.2001.0149_RF90","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood.V93.4.1271","article-title":"A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis","volume":"93","author":"de Visser","year":"1999","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0149_RF91","doi-asserted-by":"crossref","unstructured":"Haim, N. Lanir, N. Hoffman, R. Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism. Am J Med 2001 \u2013 in press.","DOI":"10.1016\/S0002-9343(00)00691-4"},{"key":"10.1054\/blre.2001.0149_RF92","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/1097-0142(20000915)89:6<1181::AID-CNCR1>3.0.CO;2-T","article-title":"Progress in anti-angiogenic gene therapy of cancer","volume":"89","author":"Feldman","year":"2000","journal-title":"Cancer"},{"key":"10.1054\/blre.2001.0149_RF93","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1054\/blre.2001.0149_RF94","first-page":"4311","article-title":"Inhibition of tumor angiogenesis by a single-chain antibody directed against vascular endothelial growth factor","volume":"60","author":"Vitaliti","year":"2000","journal-title":"Cancer Res"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X01901493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X01901493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T07:01:29Z","timestamp":1621148489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X01901493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S0268960X01901493"],"URL":"https:\/\/doi.org\/10.1054\/blre.2001.0149","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}